HEADER HYDROLASE/HYDROLASE INHIBITOR, VIRAL PRO10-JUN-19 6P9A TITLE HIV-1 PROTEASE MULTIPLE MUTANT PRS5B WITH DARUNAVIR COMPND MOL_ID: 1; COMPND 2 MOLECULE: HIV-1 PROTEASE; COMPND 3 CHAIN: B, A; COMPND 4 SYNONYM: RETROPEPSIN; COMPND 5 EC: 3.4.23.16; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 GROUP M SOURCE 3 SUBTYPE B (ISOLATE BRU/LAI); SOURCE 4 ORGANISM_COMMON: HIV-1; SOURCE 5 ORGANISM_TAXID: 11686; SOURCE 6 STRAIN: ISOLATE BRU/LAI; SOURCE 7 GENE: GAG-POL; SOURCE 8 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PJ414 KEYWDS PROTEASE, INHIBITOR, MULTIPLE MUTANT, HYDROLASE-HYDROLASE INHIBITOR, KEYWDS 2 VIRAL PROTEIN COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR D.W.KNELLER,J.AGNISWAMY,I.T.WEBER REVDAT 3 11-OCT-23 6P9A 1 REMARK REVDAT 2 19-AUG-20 6P9A 1 JRNL HETSYN REVDAT 1 15-APR-20 6P9A 0 JRNL AUTH D.W.KNELLER,J.AGNISWAMY,R.W.HARRISON,I.T.WEBER JRNL TITL HIGHLY DRUG-RESISTANT HIV-1 PROTEASE REVEALS DECREASED JRNL TITL 2 INTRA-SUBUNIT INTERACTIONS DUE TO CLUSTERS OF MUTATIONS. JRNL REF FEBS J. V. 287 3235 2020 JRNL REFN ISSN 1742-464X JRNL PMID 31920003 JRNL DOI 10.1111/FEBS.15207 REMARK 2 REMARK 2 RESOLUTION. 1.66 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0238 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.66 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.03 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 3 NUMBER OF REFLECTIONS : 29427 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.183 REMARK 3 R VALUE (WORKING SET) : 0.181 REMARK 3 FREE R VALUE : 0.215 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1537 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.66 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.71 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2127 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.17 REMARK 3 BIN R VALUE (WORKING SET) : 0.2420 REMARK 3 BIN FREE R VALUE SET COUNT : 120 REMARK 3 BIN FREE R VALUE : 0.2630 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1512 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 58 REMARK 3 SOLVENT ATOMS : 146 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 18.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.72 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.089 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.091 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.058 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.740 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.960 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.945 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1741 ; 0.012 ; 0.012 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2405 ; 1.861 ; 1.644 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 230 ; 6.983 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 66 ;37.281 ;23.182 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 309 ;12.844 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 7 ;10.493 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 243 ; 0.136 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1267 ; 0.012 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 840 ; 2.311 ; 2.140 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1060 ; 3.205 ; 3.192 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 901 ; 3.521 ; 2.461 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 2511 ; 5.877 ;30.052 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN USED IF PRESENT IN REMARK 3 THE INPUT REMARK 4 REMARK 4 6P9A COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-JUN-19. REMARK 100 THE DEPOSITION ID IS D_1000241371. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-FEB-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.9 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31010 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.660 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 200 DATA REDUNDANCY : 4.000 REMARK 200 R MERGE (I) : 0.06600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 18.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.66 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.72 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.4 REMARK 200 DATA REDUNDANCY IN SHELL : 4.10 REMARK 200 R MERGE FOR SHELL (I) : 0.49100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3NU3 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.01 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.2 M AMMONIUM PHOSPHATE AND 100 MM REMARK 280 TRIS BUFFER AT PH 7.9., VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 292K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 46.99150 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 37.00050 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 37.00050 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 70.48725 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 37.00050 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 37.00050 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 23.49575 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 37.00050 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 37.00050 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 70.48725 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 37.00050 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 37.00050 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 23.49575 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 46.99150 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5370 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10050 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -53.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 P PO4 B 102 LIES ON A SPECIAL POSITION. REMARK 375 HOH B 231 LIES ON A SPECIAL POSITION. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PO4 B 101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PO4 B 102 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PO4 B 103 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 017 A 101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PO4 A 102 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2IEN RELATED DB: PDB REMARK 900 HIV-1 PROTEASE WILD-TYPE WITH DRV DBREF 6P9A B 1 99 UNP P03367 POL_HV1BR 501 599 DBREF 6P9A A 1 99 UNP P03367 POL_HV1BR 501 599 SEQADV 6P9A LYS B 7 UNP P03367 GLN 507 ENGINEERED MUTATION SEQADV 6P9A ILE B 10 UNP P03367 LEU 510 ENGINEERED MUTATION SEQADV 6P9A ILE B 11 UNP P03367 VAL 511 ENGINEERED MUTATION SEQADV 6P9A ASP B 21 UNP P03367 GLU 521 ENGINEERED MUTATION SEQADV 6P9A VAL B 22 UNP P03367 ALA 522 ENGINEERED MUTATION SEQADV 6P9A MET B 24 UNP P03367 LEU 524 ENGINEERED MUTATION SEQADV 6P9A ASN B 35 UNP P03367 GLU 535 ENGINEERED MUTATION SEQADV 6P9A ILE B 36 UNP P03367 MET 536 ENGINEERED MUTATION SEQADV 6P9A ASP B 37 UNP P03367 SER 537 ENGINEERED MUTATION SEQADV 6P9A LYS B 41 UNP P03367 ARG 541 ENGINEERED MUTATION SEQADV 6P9A LEU B 46 UNP P03367 MET 546 ENGINEERED MUTATION SEQADV 6P9A VAL B 54 UNP P03367 ILE 554 ENGINEERED MUTATION SEQADV 6P9A HIS B 61 UNP P03367 GLN 561 ENGINEERED MUTATION SEQADV 6P9A VAL B 62 UNP P03367 ILE 562 ENGINEERED MUTATION SEQADV 6P9A PRO B 63 UNP P03367 LEU 563 ENGINEERED MUTATION SEQADV 6P9A VAL B 64 UNP P03367 ILE 564 ENGINEERED MUTATION SEQADV 6P9A VAL B 66 UNP P03367 ILE 566 ENGINEERED MUTATION SEQADV 6P9A ALA B 67 UNP P03367 CYS 567 ENGINEERED MUTATION SEQADV 6P9A VAL B 71 UNP P03367 ALA 571 ENGINEERED MUTATION SEQADV 6P9A THR B 72 UNP P03367 ILE 572 ENGINEERED MUTATION SEQADV 6P9A THR B 73 UNP P03367 GLY 573 ENGINEERED MUTATION SEQADV 6P9A ASP B 83 UNP P03367 ASN 583 ENGINEERED MUTATION SEQADV 6P9A VAL B 84 UNP P03367 ILE 584 ENGINEERED MUTATION SEQADV 6P9A ALA B 95 UNP P03367 CYS 595 ENGINEERED MUTATION SEQADV 6P9A LYS A 7 UNP P03367 GLN 507 ENGINEERED MUTATION SEQADV 6P9A ILE A 10 UNP P03367 LEU 510 ENGINEERED MUTATION SEQADV 6P9A ILE A 11 UNP P03367 VAL 511 ENGINEERED MUTATION SEQADV 6P9A ASP A 21 UNP P03367 GLU 521 ENGINEERED MUTATION SEQADV 6P9A VAL A 22 UNP P03367 ALA 522 ENGINEERED MUTATION SEQADV 6P9A MET A 24 UNP P03367 LEU 524 ENGINEERED MUTATION SEQADV 6P9A ASN A 35 UNP P03367 GLU 535 ENGINEERED MUTATION SEQADV 6P9A ILE A 36 UNP P03367 MET 536 ENGINEERED MUTATION SEQADV 6P9A ASP A 37 UNP P03367 SER 537 ENGINEERED MUTATION SEQADV 6P9A LYS A 41 UNP P03367 ARG 541 ENGINEERED MUTATION SEQADV 6P9A LEU A 46 UNP P03367 MET 546 ENGINEERED MUTATION SEQADV 6P9A VAL A 54 UNP P03367 ILE 554 ENGINEERED MUTATION SEQADV 6P9A HIS A 61 UNP P03367 GLN 561 ENGINEERED MUTATION SEQADV 6P9A VAL A 62 UNP P03367 ILE 562 ENGINEERED MUTATION SEQADV 6P9A PRO A 63 UNP P03367 LEU 563 ENGINEERED MUTATION SEQADV 6P9A VAL A 64 UNP P03367 ILE 564 ENGINEERED MUTATION SEQADV 6P9A VAL A 66 UNP P03367 ILE 566 ENGINEERED MUTATION SEQADV 6P9A ALA A 67 UNP P03367 CYS 567 ENGINEERED MUTATION SEQADV 6P9A VAL A 71 UNP P03367 ALA 571 ENGINEERED MUTATION SEQADV 6P9A THR A 72 UNP P03367 ILE 572 ENGINEERED MUTATION SEQADV 6P9A THR A 73 UNP P03367 GLY 573 ENGINEERED MUTATION SEQADV 6P9A ASP A 83 UNP P03367 ASN 583 ENGINEERED MUTATION SEQADV 6P9A VAL A 84 UNP P03367 ILE 584 ENGINEERED MUTATION SEQADV 6P9A ALA A 95 UNP P03367 CYS 595 ENGINEERED MUTATION SEQRES 1 B 99 PRO GLN ILE THR LEU TRP LYS ARG PRO ILE ILE THR ILE SEQRES 2 B 99 LYS ILE GLY GLY GLN LEU LYS ASP VAL LEU MET ASP THR SEQRES 3 B 99 GLY ALA ASP ASP THR VAL LEU GLU ASN ILE ASP LEU PRO SEQRES 4 B 99 GLY LYS TRP LYS PRO LYS LEU ILE GLY GLY ILE GLY GLY SEQRES 5 B 99 PHE VAL LYS VAL ARG GLN TYR ASP HIS VAL PRO VAL GLU SEQRES 6 B 99 VAL ALA GLY HIS LYS VAL THR THR THR VAL LEU VAL GLY SEQRES 7 B 99 PRO THR PRO VAL ASP VAL ILE GLY ARG ASN LEU LEU THR SEQRES 8 B 99 GLN ILE GLY ALA THR LEU ASN PHE SEQRES 1 A 99 PRO GLN ILE THR LEU TRP LYS ARG PRO ILE ILE THR ILE SEQRES 2 A 99 LYS ILE GLY GLY GLN LEU LYS ASP VAL LEU MET ASP THR SEQRES 3 A 99 GLY ALA ASP ASP THR VAL LEU GLU ASN ILE ASP LEU PRO SEQRES 4 A 99 GLY LYS TRP LYS PRO LYS LEU ILE GLY GLY ILE GLY GLY SEQRES 5 A 99 PHE VAL LYS VAL ARG GLN TYR ASP HIS VAL PRO VAL GLU SEQRES 6 A 99 VAL ALA GLY HIS LYS VAL THR THR THR VAL LEU VAL GLY SEQRES 7 A 99 PRO THR PRO VAL ASP VAL ILE GLY ARG ASN LEU LEU THR SEQRES 8 A 99 GLN ILE GLY ALA THR LEU ASN PHE HET PO4 B 101 5 HET PO4 B 102 5 HET PO4 B 103 5 HET 017 A 101 38 HET PO4 A 102 10 HETNAM PO4 PHOSPHATE ION HETNAM 017 (3R,3AS,6AR)-HEXAHYDROFURO[2,3-B]FURAN-3-YL(1S,2R)-3- HETNAM 2 017 [[(4-AMINOPHENYL)SULFONYL](ISOBUTYL)AMINO]-1-BENZYL-2- HETNAM 3 017 HYDROXYPROPYLCARBAMATE HETSYN 017 DARUNAVIR; TMC114; UIC-94017 FORMUL 3 PO4 4(O4 P 3-) FORMUL 6 017 C27 H37 N3 O7 S FORMUL 8 HOH *146(H2 O) HELIX 1 AA1 GLY B 86 ILE B 93 1 8 HELIX 2 AA2 GLY A 86 ILE A 93 1 8 SHEET 1 AA1 4 GLN B 2 THR B 4 0 SHEET 2 AA1 4 THR A 96 ASN A 98 -1 O LEU A 97 N ILE B 3 SHEET 3 AA1 4 THR B 96 ASN B 98 -1 N THR B 96 O ASN A 98 SHEET 4 AA1 4 GLN A 2 ILE A 3 -1 O ILE A 3 N LEU B 97 SHEET 1 AA2 8 LYS B 43 GLY B 49 0 SHEET 2 AA2 8 GLY B 52 VAL B 66 -1 O GLN B 58 N LYS B 43 SHEET 3 AA2 8 HIS B 69 VAL B 77 -1 O VAL B 75 N TYR B 59 SHEET 4 AA2 8 VAL B 32 LEU B 33 1 N LEU B 33 O LEU B 76 SHEET 5 AA2 8 VAL B 84 ILE B 85 -1 O VAL B 84 N VAL B 32 SHEET 6 AA2 8 GLN B 18 MET B 24 1 N LEU B 23 O ILE B 85 SHEET 7 AA2 8 ILE B 10 ILE B 15 -1 N ILE B 11 O VAL B 22 SHEET 8 AA2 8 GLY B 52 VAL B 66 -1 O GLU B 65 N LYS B 14 SHEET 1 AA3 8 LYS A 43 GLY A 49 0 SHEET 2 AA3 8 GLY A 52 VAL A 66 -1 O VAL A 54 N ILE A 47 SHEET 3 AA3 8 HIS A 69 VAL A 77 -1 O VAL A 71 N VAL A 64 SHEET 4 AA3 8 VAL A 32 LEU A 33 1 N LEU A 33 O LEU A 76 SHEET 5 AA3 8 VAL A 84 ILE A 85 -1 O VAL A 84 N VAL A 32 SHEET 6 AA3 8 GLN A 18 MET A 24 1 N LEU A 23 O ILE A 85 SHEET 7 AA3 8 ILE A 10 ILE A 15 -1 N ILE A 15 O GLN A 18 SHEET 8 AA3 8 GLY A 52 VAL A 66 -1 O GLU A 65 N LYS A 14 SITE 1 AC1 8 THR B 74 ASN B 88 GLN B 92 HOH B 203 SITE 2 AC1 8 HOH B 205 HOH B 210 HOH B 258 HOH B 270 SITE 1 AC2 7 VAL B 71 GLN B 92 HOH B 201 HOH B 205 SITE 2 AC2 7 HOH B 206 HOH B 208 HOH B 236 SITE 1 AC3 10 017 A 101 TRP B 6 LYS B 7 ASP B 29 SITE 2 AC3 10 ILE B 47 GLY B 48 HOH B 249 HOH B 250 SITE 3 AC3 10 HOH B 268 HOH B 269 SITE 1 AC4 21 ASP A 25 GLY A 27 ALA A 28 ASP A 29 SITE 2 AC4 21 ASP A 30 ASN A 35 GLY A 48 GLY A 49 SITE 3 AC4 21 ILE A 50 VAL A 82 HOH A 228 LYS B 7 SITE 4 AC4 21 ASP B 25 GLY B 27 ALA B 28 ASP B 30 SITE 5 AC4 21 GLY B 48 GLY B 49 VAL B 82 PO4 B 103 SITE 6 AC4 21 HOH B 249 SITE 1 AC5 8 LYS A 20 ASP A 29 ASP A 30 LYS A 45 SITE 2 AC5 8 HOH A 201 HOH A 203 HOH A 205 HOH A 207 CRYST1 74.001 74.001 93.983 90.00 90.00 90.00 P 43 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013513 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013513 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010640 0.00000